Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jun 22, 06:19

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages

Vir Biotechnology Inc
Webhose 2026 Jun 21, 08:23

Vir Biotechnology (VIR) Stock Could Be 56% Undervalued After New PSMA Data

Vir Biotechnology Inc
Webhose 2026 Jun 18, 05:29

Is Vir Biotechnology (VIR) Quietly Recasting Its Governance Strength With a New Audit Committee Chair?

Vir Biotechnology Inc
Webhose 2026 Jun 15, 00:00

Clinical Cure for Hepatitis B: Race Enters Decisive Phase, Fastest Candidate May Hit Market in 2027

Vir Biotechnology Inc
Webhose 2026 Jun 11, 14:34

Assessing Vir Biotechnology (VIR) Valuation As Timothy Coughlin Takes Board And Audit Committee Roles

Vir Biotechnology Inc
Webhose 2026 Jun 11, 12:47

Morgan Stanley Raises Vir Biotechnology (NASDAQ:VIR) Price Target to $27.00

Vir Biotechnology Inc
Webhose 2026 Jun 10, 20:05

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors | Morningstar

Vir Biotechnology Inc
Webhose 2026 Jun 10, 07:50

WINTON GROUP Ltd Buys 131,555 Shares of Vir Biotechnology, Inc. $VIR - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 07, 20:14

Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?

Vir Biotechnology Inc
Webhose 2026 Jun 07, 15:16

Does Vir Biotechnology (VIR) Board Shuffle Hint At A Deeper Shift Toward Oncology?

Vir Biotechnology Inc
Webhose 2026 Jun 05, 03:55

Vir Biotechnology (NASDAQ:VIR) Director Sells $30,240.00 in Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 05, 00:12

Reviewing Beam Therapeutics (NASDAQ:BEAM) & Vir Biotechnology (NASDAQ:VIR) - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 04, 00:20

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Vir Biotechnology (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 15:00

VIR Maintained by Leerink Partners -- Price Target Raised to $21

Vir Biotechnology Inc
Webhose 2026 Jun 03, 14:41

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $21.00

Vir Biotechnology Inc
Webhose 2026 Jun 03, 07:41

Leerink Partners Forecasts Strong Price Appreciation for Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Janet Napolitano Sells 3,200 Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 May 28, 08:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2026 May 28, 08:09

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2026 May 27, 11:07

UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc

VirBiotechnology News

gold
Julian Parker 2026 Jun 24, 16:02

Gold Price Forecast: XAU/USD Plunges to 2026 Lows Amid Hawkish Fed and Strong Dollar

commodity
usd-jpy
Julian Parker 2026 Jun 23, 16:01

USD/JPY Forecast: Analyzing the 161.60 Threshold Amid BoJ Policy Friction and Intervention Risks

forex
Julian Parker 2026 Jun 21, 16:03

Crude Oil Price Forecast 2026–2030: Macro Fundamentals, Geopolitics, and Trading Strategies

commodity
Julian Parker 2026 Jun 17, 16:02

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

forex
Julian Parker 2026 Jun 17, 16:01

SpaceX Stock Forecast 2027, 2031 and 2036: What the Lockup Schedule Means for SPCX Shares

stocks
Julian Parker 2026 Jun 16, 16:03

USD/CAD Forecast: Oil Weakness Keeps 1.4000 in Focus

forex
Julian Parker 2026 Jun 16, 16:01

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

indices
Julian Parker 2026 Jun 14, 16:05

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

cfd trading stocks
Julian Parker 2026 Jun 14, 16:02

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

stocks
Julian Parker 2026 Jun 10, 16:01

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

stocks

Latest news

Show more
micron
Julian Parker 2026 Jun 24, 16:05

Micron Projects Multi-Year Memory Shortage Following Blowout Q3 Earnings

stocks
sk-hynix
Julian Parker 2026 Jun 24, 16:04

SK Hynix Stock Surges on $29.4bn Nasdaq ADR Plan as AI Memory Demand Drives Relating Hopes

Stock
fomc
Julian Parker 2026 Jun 24, 16:03

US Dollar Tracks Toward Largest Monthly Gain in a Year Amid Resilient Economic Data

bond
wti-oil
Julian Parker 2026 Jun 24, 16:03

Crude oil major slide and gold below 4000

Morning Note
gold
Julian Parker 2026 Jun 24, 16:02

Gold Price Today, June 25: Spot Gold Plunges Below $4,000 to Hit Lowest Level Since November 2025

gold price today
micron
Julian Parker 2026 Jun 23, 16:05

Kospi's $474 Billion Rout Exposes AI Concentration Risks Ahead of Micron Report

stocks
gold-produce
Julian Parker 2026 Jun 23, 16:03

Gold Approaches Critical $4,000 Threshold as Hawkish Fed Repricing Eclipses Geopolitical Premium

gold price today
wti-oil
Julian Parker 2026 Jun 23, 16:02

WTI Crude Edges Higher but Remains Under Pressure Near $72.50 After Recent Low

Commodities

Info

Spread

0.07

Spread (%)

0.7128 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1678087040

Shares Outstanding

168651974

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.13

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Julian Parker 2026 Jun 23, 16:05

11 Best Swap-Free Account CFD Brokers in Dubai 2026

Swap-Free Account
Julian Parker 2026 Jun 23, 16:04

11 Best Swap-free Account CFD Brokers in 2026

Julian Parker 2026 Jun 22, 16:05

Do You Have to Be Muslim for a Swap-Free Account?

Trustpilot